ArticleNature nanotechnology2019

FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels.

Vicenta Trujillo-Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.